| Literature DB >> 28534255 |
Xiaohui Zhang1, Liren Wang1, Mingyao Liu2, Dali Li3.
Abstract
CRISPR/Cas9 is a versatile genome-editing tool which is widely used for modifying the genome of both prokaryotic and eukaryotic organisms for basic research and applications. An increasing number of reports have demonstrated that CRISPR/Cas9-mediated genome editing is a powerful technology for gene therapy. Here, we review the recent advances in CRISPR/Cas9-mediated gene therapy in animal models via different strategies and discuss the challenges as well as future prospects.Keywords: CRISPR/Cas9; ex vivo; gene therapy; in vivo
Mesh:
Year: 2017 PMID: 28534255 DOI: 10.1007/s11427-017-9057-2
Source DB: PubMed Journal: Sci China Life Sci ISSN: 1674-7305 Impact factor: 6.038